Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
SRS LABS INC (SRSL)
|
Add to portfolio |
|
|
|
| Price: |
$8.08
| | Metrics |
| OS: |
14.4
|
M
| |
|
% ROE
|
| Market cap: |
$117
|
M
| |
-1
|
% ROIC
|
|
Net cash:
|
$39.4
|
M
| |
$2.73
|
per share
|
|
EV:
|
$77.2
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$989.6
|
k
| |
78.0
|
x EV/EBITDA
|
|
EBIT
|
($176.9)
|
k
| |
|
|
| EPS |
$0.00
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 | Dec-31-05 | Dec-31-04 |
| Revenues | 32.9 | 31.2 | 25.0 | 18.3 | 18.9 | 18.5 | 14.6 | 10.8 |
| Revenue growth | 5.3% | 25.1% | 36.2% | -2.8% | 1.6% | 27.0% | 34.9% | -45.3% |
| Cost of goods sold | 0.8 | 0.3 | 0.3 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 |
| Gross profit | 32.1 | 30.9 | 24.7 | 18.2 | 18.7 | 18.4 | 14.4 | 10.6 |
| Gross margin | 97.6% | 98.9% | 98.9% | 99.2% | 99.1% | 99.1% | 98.4% | 97.9% |
| Sales and marketing | 14.9 | 13.5 | 11.4 | 9.2 | 6.7 | 7.3 | 5.2 | 4.6 |
| Research and development | 8.8 | 8.1 | 5.7 | 3.9 | 3.1 | 2.6 | 2.2 | 2.3 |
| General and administrative | 7.4 | 6.5 | 5.7 | 5.9 | 5.4 | 5.7 | 5.2 | 4.6 |
| EBIT | 0.9 | 2.8 | 1.9 | -0.9 | 3.4 | 2.8 | 1.8 | -0.8 |
| EBIT margin | 2.8% | 9.0% | 7.6% | -4.8% | 18.1% | 15.1% | 12.2% | -7.7% |
| Pre-tax income | 1.1 | 3.1 | 2.2 | 0.4 | 5.5 | 3.9 | 2.5 | -0.2 |
| Income taxes | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.9 | 0.8 | 0.5 |
| Tax rate | 0.9% | 1.7% | 4.4% | 30.3% | 0.8% | 22.1% | 32.4% | |
| Earnings from continuing ops | 1.1 | 3.0 | 2.1 | 0.3 | 5.4 | 3.1 | 1.7 | -0.8 |
| Earnings from discontinued ops | | | | | | 1.0 | -3.1 | 2.3 |
| Net income | 1.1 | 3.0 | 2.1 | 0.3 | 5.4 | 4.7 | -1.4 | 1.6 |
| Net margin | 3.4% | 9.6% | 8.6% | 1.5% | 28.7% | 25.4% | -9.8% | 14.6% |
| |
| Diluted EPS | $0.07 | $0.19 | $0.14 | $0.02 | $0.32 | $0.20 | $0.11 | ($0.05) |
| Shares outstanding (diluted) | 15.5 | 15.6 | 14.8 | 15.8 | 17.0 | 15.5 | 15.2 | 15.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|